Capha Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FPSUF research report →
About the company
Capha Pharmaceuticals Inc. currently conducts very limited business operations. Its strategic aim is to delve into and pursue opportunities within the pharmaceutical distribution industry.
- CEO
- James R. Brown
- IPO
- 2009
- HQ
- West Kelowna, BC, CA
Price Chart
- Market Cap
- $6.44K
- P/E
- -0.24
- P/S
- 0.00
- P/B
- -0.02
- EV/EBITDA
- -13.93
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 7.43%
- ROIC
- 931.45%
- Revenue
- $0 · 0.00%
- Net Income
- $-70,773 · -32.63%
- EPS
- $-0.00 · -37.50%
- Op Income
- $-50,745
- FCF YoY
- 3.19%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.53
- Avg Volume
- 142
Get TickerSpark's AI analysis on FPSUF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FPSUF coverage
Recent articles, reports, and earnings notes.
No research on FPSUF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FPSUF report →Similar companies
Peers in the same neighborhood.